InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Coya Therapeutics, Inc.

COYA Clue Score56
United States Fiscal year ends December CIK 0001835022
$4.95 -0.80% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.95 +18.99% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 29 Dec 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Operating income−4.9Net income−4.9EPS, diluted−1.89Fiscal year 2022Revenue0.0Operating income−9.8Net income−12.2EPS, diluted−4.73Fiscal year 2023Revenue6.0Operating income−7.9Net income−8.0EPS, diluted−0.79Fiscal year 2024Revenue3.6 −40.8%Operating income−17.2Net income−14.9EPS, diluted−0.98Fiscal year 2025Revenue7.9 +123.6%Operating income−22.6Net income−21.2EPS, diluted−1.27
FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.0 6.0 3.6 7.9
Growth −40.8% +123.6%
Operating income −4.9 −9.8 −7.9 −17.2 −22.6
Net income −4.9 −12.2 −8.0 −14.9 −21.2
Growth
EPS, diluted −1.89 −4.73 −0.79 −0.98 −1.27

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Fiscal year 2022Fiscal year 2023Operating margin−131.7%Net margin−133.1%Fiscal year 2024Operating margin−485.4%Net margin−418.7%Fiscal year 2025Operating margin−283.9%Net margin−267.1%
FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −131.7% −485.4% −283.9%
Net margin n/a n/a −133.1% −418.7% −267.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2021Operating cash flow−3.9Fiscal year 2022Operating cash flow−7.2Fiscal year 2023Operating cash flow−11.2Fiscal year 2024Operating cash flow−10.3Fiscal year 2025Operating cash flow−10.7
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −3.9 −7.2 −11.2 −10.3 −10.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash4.3Shareholders’ equity3.6Fiscal year 2022Cash5.9Shareholders’ equity−8.4Fiscal year 2023Cash32.6Shareholders’ equity35.6Fiscal year 2024Cash38.3Shareholders’ equity39.6Fiscal year 2025Cash46.8Shareholders’ equity43.0
FY2021FY2022FY2023FY2024FY2025
Cash 4.3 5.9 32.6 38.3 46.8
Shareholders’ equity 3.6 −8.4 35.6 39.6 43.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−3.9 −7.2 −11.2 −10.3 −10.7
Growth
Investment
−0.1 −0.5 −0.5 −0.0 −1.2
Financing
−0.3 9.4 38.4 16.0 20.4

Capital expenditure, dividends and buybacks are shown as money out, so negative.